TKNO Alpha Teknova, Inc.
FY2025 10-K
Alpha Teknova, Inc. (TKNO) filed its fiscal year 2025 10-K annual report with the SEC on Mar 2, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: Custom manufacturing of critical reagents for life sciences, supporting research to commercialization stages
- • New emphasis on scaling operations with investment in a new warehouse and distribution facility to improve capacity and efficiency
Risk Factors
- • Regulatory risk: compliance with Second Amended and Restated Credit Agreement net revenue covenant of $39.0M for 2025, minimum cash requirement $8.0M
- • Macroeconomic exposure: 94.4% of revenue from U.S. customers, limited international diversification with only $2.3M (5.6%) sales outside U.S. in 2025
Financial SummaryXBRL
Revenue
$41M
Net Income
-$17M
Gross Margin
33.2%
Operating Margin
-41.9%
Net Margin
-42.6%
ROE
-25.1%
Total Assets
$104M
EPS (Diluted)
$-0.32
Operating Cash Flow
-$9M
Source: XBRL data from Alpha Teknova, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Alpha Teknova, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.